chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 25.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP, FLUN3, HEPA, SMALL, TYP
Symptoms: Carbuncle, Haemoglobin normal, Leukopenia, Lymphocyte count increased, Neutrophil count decreased
Clinical narrative: This case was received on 26/June/2009 via a QScan search on VAERS database, under reference # 341520. A 25-year-old patient received the following vaccinations on 27 January 2009: smallpox vaccine (manufacturer unknown, lot number not reported), Typhim Vi, lot number B0347), hepatitis A (manufacturer and lot number unknown), and influenza (manufacturer unknown lot number 500583P). Although the manufacturer was reported as unknown in this case ACAM2000 was the only licensed smallpox vaccine at the time of the patients vaccination. Six days following vaccination, the patient was referred for persistent leukopenia since the receipt of several vaccines. Blood test results from 18 February 2009 are as follows: white blood cell count: 4.0; hemoglobin/hematocrit: 14.1/41.6; platelet: 19,000. Results from 06 March 2009 are as follows: white blood cell count: 3.9; hemoglobin/hematocrit: 13.6/39.4; platelet: 135,000. Results from 18 March 2009 are as follows: white blood cell count: 5.2; neutrophils: 1.4 and lymphocytes: 60.8. Reference ranges were not provided for any of the laboratory data. Additionally, the patient reported tendonitis, plantar warts and carbuncle on the plantar surface in a medical office visit on 09 March 2009. No additional information was provided. Note: The patient's age was reported as 25 years in the VAERS listing and reported as 26 years in the VAERS narrative. List of documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: FLUN3, HEPA, SMALL, TYP, FLUN3, HEPA, SMALL, TYP
Symptoms: Platelet count decreased, Skin papilloma, Tendonitis, White blood cell count decreased
Clinical narrative: This case was received on 26/June/2009 via a QScan search on VAERS database, under reference # 341520. A 25-year-old patient received the following vaccinations on 27 January 2009: smallpox vaccine (manufacturer unknown, lot number not reported), Typhim Vi, lot number B0347), hepatitis A (manufacturer and lot number unknown), and influenza (manufacturer unknown lot number 500583P). Although the manufacturer was reported as unknown in this case ACAM2000 was the only licensed smallpox vaccine at the time of the patients vaccination. Six days following vaccination, the patient was referred for persistent leukopenia since the receipt of several vaccines. Blood test results from 18 February 2009 are as follows: white blood cell count: 4.0; hemoglobin/hematocrit: 14.1/41.6; platelet: 19,000. Results from 06 March 2009 are as follows: white blood cell count: 3.9; hemoglobin/hematocrit: 13.6/39.4; platelet: 135,000. Results from 18 March 2009 are as follows: white blood cell count: 5.2; neutrophils: 1.4 and lymphocytes: 60.8. Reference ranges were not provided for any of the laboratory data. Additionally, the patient reported tendonitis, plantar warts and carbuncle on the plantar surface in a medical office visit on 09 March 2009. No additional information was provided. Note: The patient's age was reported as 25 years in the VAERS listing and reported as 26 years in the VAERS narrative. List of documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL, SMALL, TYP, ANTH, SMALL
Symptoms: Dyspnoea, Oral disorder, Pruritus, Pyrexia, Skin lesion
Clinical narrative: This case was received on 26/June/2009 via a QScan on the VAERS database, under reference # 341552. A 21 year-old patient received the following vaccinations on 03 March 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number VV04-003-A and anthrax (manufacturer not reported, lot number FAV148). Seven days post-vaccination the patient inoculated herself on right index finger by inadvertently scratching her vaccination site and then eating finger food. Lesions developed on her finger and in mouth and posterior pruritis, extreme fatigue, slight fever and shortness of breath, sore throat, myalgia and myositis. The patient was treated with pain medication (unspecified) for the myalgia and myositis. The patient's outcome was reported as recovered. No other information was provided. List of documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL, SMALL, TYP, ANTH, SMALL
Symptoms: Blister, Oropharyngeal blistering
Clinical narrative: This case was received on 26/June/2009 via a QScan on the VAERS database, under reference # 341552. A 21 year-old patient received the following vaccinations on 03 March 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number VV04-003-A and anthrax (manufacturer not reported, lot number FAV148). Seven days post-vaccination the patient inoculated herself on right index finger by inadvertently scratching her vaccination site and then eating finger food. Lesions developed on her finger and in mouth and posterior pruritis, extreme fatigue, slight fever and shortness of breath, sore throat, myalgia and myositis. The patient was treated with pain medication (unspecified) for the myalgia and myositis. The patient's outcome was reported as recovered. No other information was provided. List of documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL, SMALL, TYP, ANTH, SMALL
Symptoms: Dyspnoea, Fatigue, Myalgia, Myositis, Oropharyngeal pain
Clinical narrative: This case was received on 26/June/2009 via a QScan on the VAERS database, under reference # 341552. A 21 year-old patient received the following vaccinations on 03 March 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number VV04-003-A and anthrax (manufacturer not reported, lot number FAV148). Seven days post-vaccination the patient inoculated herself on right index finger by inadvertently scratching her vaccination site and then eating finger food. Lesions developed on her finger and in mouth and posterior pruritis, extreme fatigue, slight fever and shortness of breath, sore throat, myalgia and myositis. The patient was treated with pain medication (unspecified) for the myalgia and myositis. The patient's outcome was reported as recovered. No other information was provided. List of documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: ANTH, SMALL, SMALL, TYP, ANTH, SMALL
Symptoms: Post vaccination autoinoculation, Pruritus, Pyrexia, Skin lesion, Stomatitis
Clinical narrative: This case was received on 26/June/2009 via a QScan on the VAERS database, under reference # 341552. A 21 year-old patient received the following vaccinations on 03 March 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number VV04-003-A and anthrax (manufacturer not reported, lot number FAV148). Seven days post-vaccination the patient inoculated herself on right index finger by inadvertently scratching her vaccination site and then eating finger food. Lesions developed on her finger and in mouth and posterior pruritis, extreme fatigue, slight fever and shortness of breath, sore throat, myalgia and myositis. The patient was treated with pain medication (unspecified) for the myalgia and myositis. The patient's outcome was reported as recovered. No other information was provided. List of documents held by sender: None.
Age: 43.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Injection site cellulitis
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 341834. A 43-year-old patient received the following vaccination on 04 March 2009: ACAM2000 (lot number VV04-003-A). Nine days post vaccination the patient developed an area of cellulitis at the vaccination site. The patient outcome was reported as recovered. No additional information was provided. List of documents held by sender: none.
Age: 43.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Injection site cellulitis
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 341835. A 43-year-old patient received the following vaccination on 04 March 2009: ACAM2000 (lot number VV04-003-A). Nine days post vaccination the patient developed an area of cellulitis at the vaccination site. The patient's outcome was reported as recovered. No other information was provided. List of documents held by sender: none.
Age: 25.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Pain, Rash papular, Serum sickness, Type II hypersensitivity
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 342019. A 25-year-old patient received the following vaccination on 07 March 2009: ACAM200 (lot number VV04-003-A), Typhim Vi (lot number A0221) and Biothrax, Emergent Bisolutions, lot number FAV149. Eight days post vaccination the patient reported small bumps on chest, back and head painful to touch. The patient was seen by a physician who diagnosed it as Type II hypersensitivity - serum sickness. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 25.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Pain, Rash, Serum sickness, Type II hypersensitivity
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 342019. A 25-year-old patient received the following vaccination on 07 March 2009: ACAM200 (lot number VV04-003-A), Typhim Vi (lot number A0221) and Biothrax, Emergent Bisolutions, lot number FAV149. Eight days post vaccination the patient reported small bumps on chest, back and head painful to touch. The patient was seen by a physician who diagnosed it as Type II hypersensitivity - serum sickness. The outcome of the patient was not reported. No additional information was provided. List of documents held by sender: None.
Age: 53.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Asthenia, Chest X-ray normal, Cough, Dizziness, Full blood count normal
Clinical narrative: This case was received on 26/June?2009 via a QScan search on the VAERS database, under reference # 342052. A 53 year-old patient received the following vaccinations on 15 March 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number W04003A), and anthrax (Biothrax, Emergent Bicsolutions, lot number FAV135). On the same day as vaccination, the subject experienced cough, wheezing, headache, fever of 103 degrees Fahrenheit, tachycardia, nausea, sore throat, myalgia, general weakness and dizziness on standing. Testing done on 15 March 2009 included a normal chest x-ray, normal complete blood count and normal Chemistry-7 panel. Actual results and reference ranges were not reported. A diagnosis was not provided. The outcome of the patient was reported as recovered.
Age: 53.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Headache, Metabolic function test normal, Myalgia, Nausea, Oropharyngeal pain
Clinical narrative: This case was received on 26/June?2009 via a QScan search on the VAERS database, under reference # 342052. A 53 year-old patient received the following vaccinations on 15 March 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number W04003A), and anthrax (Biothrax, Emergent Bicsolutions, lot number FAV135). On the same day as vaccination, the subject experienced cough, wheezing, headache, fever of 103 degrees Fahrenheit, tachycardia, nausea, sore throat, myalgia, general weakness and dizziness on standing. Testing done on 15 March 2009 included a normal chest x-ray, normal complete blood count and normal Chemistry-7 panel. Actual results and reference ranges were not reported. A diagnosis was not provided. The outcome of the patient was reported as recovered.
Age: 53.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Pyrexia, Tachycardia, Wheezing
Clinical narrative: This case was received on 26/June?2009 via a QScan search on the VAERS database, under reference # 342052. A 53 year-old patient received the following vaccinations on 15 March 2009: smallpox vaccinia vaccine, live (ACAM2000, lot number W04003A), and anthrax (Biothrax, Emergent Bicsolutions, lot number FAV135). On the same day as vaccination, the subject experienced cough, wheezing, headache, fever of 103 degrees Fahrenheit, tachycardia, nausea, sore throat, myalgia, general weakness and dizziness on standing. Testing done on 15 March 2009 included a normal chest x-ray, normal complete blood count and normal Chemistry-7 panel. Actual results and reference ranges were not reported. A diagnosis was not provided. The outcome of the patient was reported as recovered.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Alanine aminotransferase increased, Anion gap, Aspartate aminotransferase increased, Basophil count decreased, Blood albumin normal
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood alkaline phosphatase increased, Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase increased, Blood creatinine increased
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood glucose normal, Blood osmolarity decreased, Blood potassium decreased, Blood sodium normal, Blood urea normal
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Carbon dioxide increased, Chest discomfort, Chest pain, Eosinophil count increased, Haematocrit normal
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Haemoglobin normal, Lymphocyte count normal, Mean cell haemoglobin concentration, Mean cell haemoglobin normal, Mean cell volume
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Mean platelet volume normal, Monocyte count increased, Neutrophil count normal, Platelet count normal, Protein total normal
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Red blood cell abnormality, Red cell distribution width, Troponin increased, White blood cell count increased
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Anion gap normal, Axillary pain, Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase MB increased
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood creatine phosphokinase increased, Blood creatinine increased, Blood glucose normal, Blood osmolarity decreased, Blood potassium normal
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood sodium normal, Blood urea normal, Carbon dioxide normal, Chest discomfort, Chest pain
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Electrocardiogram abnormal, Injection site pain, Myopericarditis, Troponin I increased
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Anion gap increased, Axillary pain, Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase MB increased
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood creatine phosphokinase increased, Blood creatinine increased, Blood glucose normal, Blood osmolarity decreased, Blood potassium decreased
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Blood sodium normal, Blood urea nitrogen/creatinine ratio, Blood urea normal, Carbon dioxide normal, Chest discomfort
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 22.0
Sex: M
Vaccine: FLU3, SMALL, TYP, FLU3, SMALL, TYP, FLU3, SMALL, TYP
Symptoms: Chest pain, Electrocardiogram abnormal, Injection site pain, Myopericarditis, Troponin I increased
Clinical narrative: This case was received by sanofi pasteur on 26 June 2009 via a QScan search on the VAERS database, under reference number 342176. A 22 year old male received ACAM2000, (lot number W04003AO, TYPHIM VI (lot number B04242), and FLUZONE (U2941AA) on 04 March 2009. Eleven days later, the patient developed tightness and intermittent pain in his chest. He was hospitalized and diagnosed with myopericarditis. He also experienced increased tenderness at the injection site and left axilla pain. Records from the patient's two-day hospital stay include the following test results: an abnormal electrocardiogram; CK, 450; CK MMB, 14.9; Troponin I, 6.14; Glucose, 96; Urea nitrogen, 10; CREAT, 1.3; BUN/CREATININE, 7.7; Sodium, 140; Potassium, 3.4; Chloride, 99; Carbon dioxide, 29; anion GAP 4, 15; Osmolality, Calc, 269; and Calcium, 9.6. The patient was treated with aspirin. He remained stable and his pain decreased. The patient was discharged to home with a recommendation for cardiac follow-up. The patient was reported to have recovered from the event. Note: The report states that the patient went to the hospital on 15 March 2009. However, the medical records referenced in the report are for a hospitalization on 16 March 2009 and 17 March 2009. List of Documents held by Sender: None.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Basophil count decreased, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood bilirubin normal, Blood calcium normal, Blood chloride normal, Blood creatinine normal, Blood glucose normal
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea normal, Carbon dioxide normal, Eosinophil count decreased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Haematocrit normal, Haemoglobin normal, Lymphocyte count, Mean cell haemoglobin concentration, Mean cell haemoglobin normal
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Mean cell volume, Mean platelet volume increased, Monocyte count, Neutrophil count, Petechiae
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Platelet count normal, Protein total normal, Rash, Red blood cell count normal, Red blood cell sedimentation rate decreased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Red cell distribution width normal, Urine analysis normal, White blood cell count increased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Haematocrit normal, Haemoglobin normal, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Petechiae, Platelet count normal, Rash, Red blood cell count normal, Red cell distribution width normal
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: White blood cell count increased
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under the reference # 342416. A 27 year old patient received ACAM2000 (lot number not reported) On 09 February 2009. Ten days after vaccination, the patient developed a rash. Petechiae was also noted. The patient had dental surgery one day after vaccination. He was treated with Amoxicillin, Motrin and Percocet. The rash may have a drug eruption related to these medications. Laboratory tests performed on 24 February include: WBC, 11.4; RBC, 5.2; Hemoglobin, 15.8; Hematocrit, 48.0; MCV, 92.3; MCH, 30.4; MCHC, 32.9; RDW CV, 12.8; and Platelet, 258. No additional information was reported. Note: Although the manufacturer was reported on unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. List of documents held by sender: none.
Age: 24.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Electrocardiogram normal, Pericardial disease
Clinical narrative: This case was received on 26/June/2009 via a QScan on the VAERS database, under reference # 342455. A 24-year-old patient received the following vaccinations on 08 December 2008: ACAM2000 (lot number not reported), Typhim Vi (lot number B0347) and Biothrax (Emergent Biosolutions, lot number not reported). Fourteen days after vaccination, unspecified disease of the pericardium was reported. An electrocardiogram was performed on 10 February 2009 with normal results. No diagnosis or additional information was provided. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional study. List of documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram abnormal, Myocarditis, Troponin I increased
Clinical narrative: This case was received on 26/June?2009 via a QScan on the VAERS database, under reference # 342457. A 23 year old male patient received ACAM2000 (lot number unknown) on 12 January 2009. Non-specific myocarditis was with an onset of 10 days after vaccination. The patient had an electrocardiogram and Troponin I performed and both were reported as abnormal. No other information was provided. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study.
Age: 22.0
Sex: M
Vaccine: MMR, SMALL, TYP, MMR, SMALL, TYP
Symptoms: Electrocardiogram, Nuclear magnetic resonance imaging, Pericarditis, Troponin I
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 342458. A 22-year-old patient received the following vaccinations on 09 December 2008: ACAM2000 (sanofi pasteur Biologics Co, lot number VV04-003A), Typhim Vi, lot number B034A and MMRII, Merck, lot number 1248X. Unspecified acute pericarditis was reported. Troponin I and an electrocardiogram were performed on 19/December/2008 and an MRI was performed on 22/December/2008. Results from these tests were not reported. No additional information was reported. Note: There is no reported causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: none.
Age: 26.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram, Pericarditis, Troponin I
Clinical narrative: This case was received on 26 June 2009 via a QScan search on the VAERS database, under reference # 342459. A 26 year-old male patient received ACAM2000 (lot number unknown) on 18 December 2008. Eleven days after vaccination, the patient is reported to have acute pericarditis. An electrocardiogram and Troponin I were performed. Test results were not reported. No additional information was provided. Note: There is no reported causality assesments as this is a safety surveillance (data mining, non-interventioanal) study. List of documents held by senders: None.